KPMP Kidney Mapping and Atlas Project (KMAP)
KPMP 肾脏绘图和图集项目 (KMAP)
基本信息
- 批准号:10492787
- 负责人:
- 金额:$ 196万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Acute Renal Failure with Renal Papillary NecrosisAddressAnatomyAtlasesBioinformaticsBiometryBiopsyCellsChronic Kidney FailureClinicalCollaborationsCommunitiesCommunity OutreachDataData AnalysesData DisplayData SetData Storage and RetrievalDiseaseEcosystemEnsureEnvironmentFAIR principlesFundingFutureGenerationsGoalsHealthHuman BioMolecular Atlas ProgramInstitutionJointsKidneyKidney DiseasesKnowledgeLeadLeadershipMapsMetadataMichiganMolecularNephrologyOntologyParticipantPathologistPathologyPathway interactionsPatientsPhasePhilosophyPlant RootsProcessQuality ControlResearchResearch PersonnelRiskRoleRouteScienceServicesSiteStratificationStructureStudentsSystemSystems BiologyTissue atlasTissuesUniversitiesWashingtoncloud basedcollaborative environmentcomputerized data processingdata curationdata disseminationdata integrationdata managementdata modelingdata visualizationdesigndigital pathologydisorder subtypediversity and equityexperienceflexibilitygenomic dataindexinginterstitialmultimodal datamultimodalitynephrogenesisnew therapeutic targetoutreachparticipant safetypatient engagementprecision medicinerecruitresearch studyresponseskillssocialsoftware developmentstructured datasuccesstoolwebsite development
项目摘要
ABSTRACT
The overarching objective of the Kidney Mapping Atlas Project (KMAP) in response to the Kidney Tissue Atlas
Coordinating Center (KTACC) application is to create and support the central data management, integration
and dissemination platform for the Kidney Precision Medicine Project (KPMP). Our focus for the KMAP will be
centered around the key values established by us in the first funding cycle of KPMP: a collaborative
environment committed to promoting participant safety and engagement, scientific rigor, and outreach to the
global renal research community anchored in a concept of interdisciplinary team science necessary to drive
disruptive advances in kidney precision medicine. We plan to extend our highly experienced team successfully
navigating the multiple inherent challenges during the startup phase of KPMP to address the key opportunities
and challenges of the next phase of KPMP. To this end have assembled domain expertise in nephrology,
nephro- and digitial pathology, anatomy, ontology, data curation, biostatistics, bioinformatics, renal systems
biologists, data visualization, kidney user experience, website and software development. Our overarching
principle will continue to be an uncompromising commitment to our patient partners co-leading our efforts and
a sharp focus on rigorous QC and QC in tight coordination with the KPMP Central Hub, the Tissue
Interrogation and Recruitment Sites and Opportunity pool awardees.
We have pioneered a team science structure to advance a precision medicine approach to kidney disease with
the development of the KPMP data management, integration and sharing framework strongly routed in FAIR
principles. We share a common philosophy that our role is one of service, collaboration, and leadership with
over 30 years of experience coordinating highly successful large-scale research studies into the molecular
mechanism of kidney disease always supporting diversity, equity and inclusion in all aspects of renal precision
medicine research. The KMAP will be led by Drs. Kretzler (University of Michigan) and Himmelfarb (University
of Washington) with complementary expertise and an extensive track record in working together to lead
clinical, translational and bench kidney precision medicine studies and will ensure the seamless integration of
KMAP into the KPMP ecosystem.
KMAP will serve its function via three main units. The KMAP Data Management Core (DMC) will be
responsible to clean, harmonize, register, store and curate the diverse current and future KPMP data. The
KMAP Data Analysis Hub (DAH) will integrate the multimodal data along the continuum of clinical, social-risk,
spatial, ontological, digital-pathology and molecular data sets to identify key drivers of disease processes.
Finally, the KMAP Data Visualization Hub (DAV) will develop, maintain and distribute a multi-dimensional
atlas of kidney health and disease via a flexible computation environment.
Tight integration of the KMAP efforts with HuBMAP, HCA and RBK/GUDMPA together with strong leadership
skills of the PIs will ensure effective implementation across KPMP and the biomedical community at large.
摘要
肾组织图谱项目(KMAP)的总体目标
协调中心(KTACC)的应用是创建和支持中央数据管理、集成
和肾脏精准医学项目(KPMP)的传播平台。我们对KMAP的重点将是
围绕着我们在KPMP的第一个供资周期中建立的关键价值观:协作性
致力于促进参与者的安全和参与度、科学严谨性以及与
全球肾脏研究社区扎根于跨学科团队科学的概念,这是推动
肾脏精准医学的颠覆性进展。我们计划成功地扩大我们经验丰富的团队
在KPMP的启动阶段应对多重固有挑战,以抓住关键机遇
以及下一阶段淘汰管理计划所面临的挑战。为此,他们汇集了肾脏病领域的专业知识,
肾脏和数字病理学、解剖学、本体论、数据管理、生物统计学、生物信息学、肾脏系统
生物学家、数据可视化、肾脏用户体验、网站和软件开发。我们最重要的是
原则将继续是对我们的患者伙伴的不妥协承诺,共同领导我们的努力和
严格的QC和QC与KPMP中心中心、组织的紧密协调
审讯和招聘网站以及机会池获奖者。
我们开创了团队科学结构,通过以下方式推进肾脏疾病的精确医学方法
KPMP数据管理、整合和共享框架的开发在广交会上得到了大力支持
原则。我们有一个共同的理念,即我们的角色是服务、协作和领导
30多年协调非常成功的大规模分子研究研究的经验
肾脏疾病的机制始终支持肾脏精确度的各个方面的多样性、公平性和包容性
医学研究。KMAP将由Kretzler博士(密歇根大学)和Himmelfarb博士(大学)领导
拥有互补的专业知识和广泛的合作记录,共同领导
临床、转化和基准肾脏精准医学研究,并将确保无缝集成
将KMAP纳入KPMP生态系统。
KMAP将通过三个主要单位履行其职能。KMAP数据管理核心(DMC)将是
负责清理、协调、登记、存储和管理各种当前和未来的KPMP数据。这个
KMAP数据分析中心(DAH)将沿着临床、社会风险、
空间、本体论、数字病理学和分子数据集,以确定疾病过程的关键驱动因素。
最后,KMAP数据可视化中心(DAV)将开发、维护和分发多维
通过灵活的计算环境提供肾脏健康和疾病地图集。
KMAP努力与HuBMAP、HCA和RBK/GUDMPA紧密结合,并具有强大的领导力
绩效指标的技能将确保在KPMP和整个生物医学界有效实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Himmelfarb其他文献
Jonathan Himmelfarb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Himmelfarb', 18)}}的其他基金
KPMP Kidney Mapping and Atlas Project (KMAP)
KPMP 肾脏绘图和图谱项目 (KMAP)
- 批准号:
10705740 - 财政年份:2022
- 资助金额:
$ 196万 - 项目类别:
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
使用芯片肾微生理系统进行人体临床试验的安全性和有效性
- 批准号:
10037553 - 财政年份:2020
- 资助金额:
$ 196万 - 项目类别:
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
使用芯片肾微生理系统进行人体临床试验的安全性和有效性
- 批准号:
10671573 - 财政年份:2020
- 资助金额:
$ 196万 - 项目类别:
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
使用芯片肾微生理系统进行人体临床试验的安全性和有效性
- 批准号:
10216377 - 财政年份:2020
- 资助金额:
$ 196万 - 项目类别:
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
使用芯片肾微生理系统进行人体临床试验的安全性和有效性
- 批准号:
10471014 - 财政年份:2020
- 资助金额:
$ 196万 - 项目类别:
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
使用芯片肾微生理系统进行人体临床试验的安全性和有效性
- 批准号:
10515788 - 财政年份:2020
- 资助金额:
$ 196万 - 项目类别:
Effects of microgravity on the structure and function of proximal and distal tubule MPS
微重力对近远曲小管MPS结构和功能的影响
- 批准号:
9890028 - 财政年份:2017
- 资助金额:
$ 196万 - 项目类别:
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
用于肾脏疾病建模和药效测试的微生理系统
- 批准号:
9757837 - 财政年份:2017
- 资助金额:
$ 196万 - 项目类别:
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing
用于肾脏疾病建模和药效测试的微生理系统
- 批准号:
9975953 - 财政年份:2017
- 资助金额:
$ 196万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 196万 - 项目类别:
Research Grant